The TP508 Solution for Nuclear Radiation Exposure

Increasing Threat of a Nuclear Accident or Intentional Detonation

Preclinical studies demonstrate that TP508 injection 24 hours after lethal doses of nuclear radiation significantly increases survival. Extensive research indicates that TP508 treatment following a nuclear incident could prevent mortality in individuals exposed to high levels of radiation and reduce delayed effects of radiation to increase quality of life for survivors.

  • Potential that hundreds of thousands of people exposed to high levels of nuclear radiation will suffer from acute radiation syndromes (ARS) or delayed organ failure
  • Risk to military and first-responders who must enter highly radioactive areas
  • Need for easily administered and highly effective medicinal countermeasures
  • TP508 mitigates radiation damage to significantly increase survival